Author: Aldika Akbar, M. I.; Gumilar, K. E.; Rahestyningtyas, E.; Wardhana, M. P.; Mulawardhana, P.; Anas, J. Y.; Ernawati, E.; Cahya Laksana, M. A.; Joewono, H. T.
Title: Cohort Study: The Accuracy of Screening Methods of COVID-19 in Pregnancy: Practical Approach in Low Resources Health Services Cord-id: d9a5exn2 Document date: 2021_9_26
ID: d9a5exn2
Snippet: Background All pregnant women in labor should be universally screened for Coronavirus Disease 2019 (COVID-19) during pandemic periods using Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) test. In many low-middle income countries, screening method was developed as an initial examination because of limited availability of RT-PCR tests. Objectives This study aims to evaluate the screening methods of COVID-19 accuracy in pregnant women. Material and Methods We recruited all pregnant women
Document: Background All pregnant women in labor should be universally screened for Coronavirus Disease 2019 (COVID-19) during pandemic periods using Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) test. In many low-middle income countries, screening method was developed as an initial examination because of limited availability of RT-PCR tests. Objectives This study aims to evaluate the screening methods of COVID-19 accuracy in pregnant women. Material and Methods We recruited all pregnant women with suspicion of COVID-19 from April - August 2020 at Universitas Airlangga hospital, Surabaya, Indonesia. The participant was divided into two groups based on RT-PCR results: COVID-19 and non-COVID-19 group. The proportion of positive signs & symptoms, rapid antibody test, abnormal findings in chest x-ray, and neutrophil to lymphocyte ratio (NLR) value were then compared between both groups. The sensitivity, specificity, positive predictive value (PPV), negative predictive values (NPV), and diagnostic accuracy (DOR) were calculated. Results A total 141 pregnant women with suspected COVID-19 cases were recruited for this study. This consist of 62 COVID-19 cases (43.9%) and 79 non COVID-19 pregnant women (56.1%). The sensitivity, spesificity, PPV, NPV, and diagnostic accuracy of each parameter are as follow: clinical sign & symptoms (24.19%, 75.95%, 3.92%, 96.11%, 65.87%), rapid antibody test (72.73%, 35.06%, 4.35%, 96.94%, 36.53%), chest x-ray (40.68%, 59.45%, 3.92%, 96.11%, 58.76%), and NLR > 5.8 (41.38%, 72%, 5.66%, 96.80%, 70.81%). Conclusions The use of combined screening methods can classify pregnant women with high-risk COVID-19 before definitively diagnosed with RT-PCR. This practice will help to reduce RT-PCR need in a limited resources country.
Search related documents:
Co phrase search for related documents- abnormal distribution and lymphocyte ratio: 1
- accuracy specificity and low middle: 1, 2, 3, 4, 5, 6
- accuracy specificity and low middle income country: 1
- accuracy specificity and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accuracy specificity and low specificity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- accuracy specificity and lymphocyte count: 1, 2, 3, 4, 5
- accuracy specificity and lymphocyte ratio: 1, 2, 3, 4, 5, 6, 7, 8
- accuracy specificity high sensitivity and low middle: 1
- accuracy specificity high sensitivity and low middle income country: 1
- accuracy specificity high sensitivity and low sensitivity: 1, 2
- accuracy specificity high sensitivity and low specificity: 1, 2
- accuracy specificity high sensitivity and lymphocyte count: 1
- additional examination and low sensitivity: 1
- additional test and low middle: 1
- additional test and low sensitivity: 1, 2
- additional test and low specificity: 1, 2
- low accuracy and lymphocyte ratio: 1
- low middle and lymphocyte count: 1, 2
- low middle and lymphocyte ratio: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date